Methemoglobinemia in patients with Plasmodium vivax receiving oral therapy with primaquine;Metemoglobinemia em pacientes com malária por plasmodium vivax em uso oral de primaquina

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 44, Issue 1, 2011, Pages 113-115

  Ferreira, Michelli Erica Souza ^a   do Socorro Mendonça Gomes, Margarete ^a   Vieira, José Luiz Fernandes ^a  

^a FEDERAL UNIVERSITY OF PARÁ   (Brazil)

Author keywords

Malaria; Methemoglobinemia; Primaquine

Indexed keywords

GLUCOSE 6 PHOSPHATE DEHYDROGENASE; PRIMAQUINE;

ARTICLE; HUMAN; METHEMOGLOBINEMIA; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; PROTEIN EXPRESSION; QUANTITATIVE ASSAY; SPECTROPHOTOMETRY;

PLASMODIUM VIVAX;

EID: 79952054902     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0037-86822011000100026     Document Type: Article

References (15)

1. Ministério da Saúde. Manual de Terapêutica da Malária. 6a ed. Brasília: Fundação Nacional de Saúde; 2001. p. 23-61.
2. Vale N, Nogueira F, Rosário VE, Gomes P, Moreira R. Primaquine dipeptide derivatives bearing na imidazolidin-4-one moiety at the N-terminus as potential anyimalarial prodrugs. Eur J Med Chem 2009; 44:2506-2516.
3. Lopez-Antuñano FJ. Is primaquine useful and safe as true exo-erythrocytic merontocidal, hypnozoitocidal and gametocidal antimalarial drug? Salud Publica Mex 1999; 41:410-419.
4. Vale N, Moreira R, Gomes P. Primaquine revised six decades after its discovery. Eur J Med Chem 2009; 44:937-953.
5. Clayman CB, Arnold J, Hockwald RS, Yount-Jr EH, Edgcomb JH, Alving AS. Toxicity of primaquina in Caucasians. J Am Med Inform Assoc 1952; 149: 1563-1568.
6. Hockwald RS, Arnold J, Clayman CB, Alving MD. Toxicity of primaquine to negroes. J Am Med Assoc 1952; 149:1568-1570.
7. Santana MS, Rocha MAF, Arcanjo ARL, Sardinha JFJ, Alecrim WD, Alecrim MGC. Associação de metemoglobinemia e defciência de glicose-6-fosfato desidrogenase em pacientes com malária tratados com primaquina. Rev Soc Bras Med Trop 2007; 40:533-536.
8. Bolchoz LJC, Budinsky R, Mcmillan DC, Jollow DJ. Primaquine-Induced Hemolytic Anemia: Formation and Hemotoxicity of the Arylhydroxylamine Metabolite 6-Methoxy-8-hydroxylaminoquinoline. J Pharmacol Exp Ther 2001; 297:509-515.
9. Hegesh E, Gruener RN, Cohen S, Bochkovsky R, Shuval HI. A sensitive micromethod for the determination of methemoglobin in blood. Clin Chim Acta 1970; 30:679-682.
10. Brewer GJ, Tarlov AR, Alving AS. The methemoglobin Reduction test for primaquina-type sensitive of erythrocytes. J Am Med Assoc 1962; 180: 386-388.
11. Hill DR, Baird JK, Parise ME, Lewis LS, Ryan ET, Magill AJ. Primaquine: Report From CDC Expert Meeting on Malaria Chemoprophylaxis I. Am J Trop Hyg 2006; 65:402-415.
12. Fletcher K, Evans DAP, Gilles HM, Greaves J, Bunnag D, Harinasuta T. Studies on the Pharmacokinetcs of Primaquine. J Public Health: Bull World Health Organ 1981; 3:407-412.
13. Bangchand KN, Songsaeng W, Thanavibul A, Choroenlarp P, Karbwang J. Phamacokinecs of Primaquine in G6PD deficient and G6PD normal patients with vivax malaria. J Trans Royal Soc Trop Med Hyg 1994; 88:220-222.
14. Krudsood S, Tangpukdee N, Wilairatana P, Phophak N, Baird K, Britenham MG, et al. High-dose Primaquine Regimens Against Relapse of Plasmodium vivax Malaria. Am J Trop Med Hyg 2008; 78:736-740.
15. Carmona-Fonseca J, Álvarez G, Maestre A. Methemoglobinemia and Adverse Events in Plasmodium vivax Malaria Patients Associated with High Doses of Primaquine Treatment. Am J Trop Med Hyg 2009; 80:188-193.